Research and Clinical Trials

Meet the investigator: Tanios S. Bekaii-Saab

By Nicole Ferrara • December 14, 2018
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Tanios S. Bekaii-Saab, M.D., a medical oncologist at Mayo Clinic in Phoenix/Scottsdale, Arizona, explains how his research interests grew out of a desire to improve treatment options for his patients.

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Breakthrough in treatment approach showing promise in the fight against glioblastoma

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Novel oncolytic immunotherapy shows promise for people with bladder cancer

Study demonstrates potentially effective treatment for people with bladder cancer who no longer respond to Bacillus Calmette-Guérin (BCG).